Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil

NCT03399604 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Pulmonary Hypertension

Interventions

DRUG: LIQ861 Inhaled Treprostinil

Sponsor

Liquidia Technologies, Inc.

Collaborators

[object Object]